Dermatology Medical Library

Created with Quartz v5.0.0 ยฉ 2026

  • ๐Ÿ› ๅœ–ๆ›ธ้คจ้ฆ–้ 
  • ๐Ÿ“— McKee ็—…็†
  • ๐Ÿ“™ ็šฎ่†šๅค–็ง‘
  • ๐Ÿ“• Fitzpatrick ็šฎ่†š็ง‘
  • ๐Ÿ“” Bolognia ็šฎ่†š็ง‘
  • ๐Ÿ“˜ Color Atlas ๅœ–่ญœ
  • ๐Ÿ“ ๅฐˆ็ง‘่€ƒ้กŒ
  • ๐Ÿ“„ ่ซ–ๆ–‡ๆ–ฐ็Ÿฅ

guselkumab

3 items with this tag.

  • Aug 01, 2026

    Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies.

    • dermatology
    • adverse_cutaneous_drug_reactions
    • ixekizumab
    • leukocytoclastic_vasculitis
    • psoriasis
    • guselkumab
  • Aug 01, 2026

    Ostraceous psoriasis in end-stage renal disease: A delayed phenotype switch from dupilumab treated with guselkumab.

    • dermatology
    • adverse_cutaneous_drug_reactions
    • dupilumab
    • guselkumab
    • ostraceous_psoriasis
    • end_stage_renal_disease
  • Jul 01, 2026

    Safe seroconversion after receiving measles, mumps, and rubella live vaccine during guselkumab treatment for psoriasis.

    • dermatology
    • psoriasis_psoriasiform_and_pityriasiform
    • guselkumab
    • psoriasis
    • mmr_vaccine
    • il23_inhibitor

Created with Quartz v5.0.0 ยฉ 2026

  • ๐Ÿ› ๅœ–ๆ›ธ้คจ้ฆ–้ 
  • ๐Ÿ“— McKee ็—…็†
  • ๐Ÿ“™ ็šฎ่†šๅค–็ง‘
  • ๐Ÿ“• Fitzpatrick ็šฎ่†š็ง‘
  • ๐Ÿ“” Bolognia ็šฎ่†š็ง‘
  • ๐Ÿ“˜ Color Atlas ๅœ–่ญœ
  • ๐Ÿ“ ๅฐˆ็ง‘่€ƒ้กŒ
  • ๐Ÿ“„ ่ซ–ๆ–‡ๆ–ฐ็Ÿฅ